Study and manufacture of natural Surfactant for the treatment of RDS
Contracted by a leading international multinational to develop and manufacture natural Surfactant for the treatment of Neonatal Respiratory Distress Syndrome (RDS).
Previous PostStart of the manufacture of porcine pulmonary Surfactant in the dedicated new manufacturing site
Next PostDevelopment of a low-molecular-weight Heparin
